We can't find the internet
Attempting to reconnect
16018.2 PFLS-LS
Targeting of the IL-23 Receptor to eliminate auto-reactive lymphocytes in chronic inflammatory diseases
Zusammenfassung
Targeting of the IL-23 Receptor to eliminate auto-reactive lymphocytes in chronic inflammatory diseases
Weitere Texte
Abstract
A novel mechanism of action for the sustainable therapy of human chronic inflammatory diseases, acting|through targeted lysis of disease-driving cell, shall be investigated here. A lead molecule active in human|and non-human primates has been identified and will be developed to enable clinical testing. To support|the preclinical development a bispecific surrogate antibody fragment active in mice will be engineered and|tested in relevant mouse models for chronic inflammatory diseases to study efficacy as well as certain|safety relevant parameters.
Beteiligte
David Urech
Wirtschaftspartner
d.urech@numab.com
Numab AG David Urech Einsiedlerstrasse 34 8820 Wädenswil ZH CH
Burkhard Becher
Kontaktperson
becher@immunology.uzh.ch
Universität Zürich Burkhard Becher Winterthurerstrasse 190 8057 Zürich ZH CH
Projektdetails
- Forschungsstelle
- INNOSUISSE
- Projektstatus
- Abgeschlossen
- Projekttyp
- Forschungsprojekt
- Startdatum
- 2014-02-28
- Enddatum
- 2016-12-31
- Bewilligte Gesamtkosten
- CHF 690580.00
- Sektion
- 20 Förderbereich Life Sciences
- NABS Politikbereich
- Industrielle Produktivität und Technologie
Forschungsdisziplinen
- T490 Biotechnology 100.0%